Oxis International has received a Generally Recognized as Safe (GRAS) status for its patented anti-oxidant - L-ergothioneine.
Subscribe to our email newsletter
The company claimed that the body has a specific gene to produce an ergothioneine transporter.
It also claimed that the L-ergothioneine has shown specific promise in extending healthy lifespans, cognitive function, and lung and heart health.
An independent panel of experts reached a decision after a review of the safety, toxicology and proposed usage of Oxis’ synthetic L-ergothioneine that it is safe for use in dietary supplements, food and beverage products.
Oxis CEO David Saloff said achieving GRAS status for their L-ergothioneine opens the door wide to significant new commercial opportunities for the company including the multi-billion dollar market segment for functional foods and beverages.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.